Health
RPT-Lonza confident of 2020 target for Moderna COVID-19 vaccine supply – Reuters
Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year…
(Repeating to add TV in slug)
* Lonza confident on 2020 target for Moderna vaccine
* Swiss locals watching, hoping for project success
* Swiss company focusing on drugs, selling chemicals unit
VISP, Switzerland, Sept 29 (Reuters) – Lonza is confident that U.S. and Swiss plants it is building to help make Modernas COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.
New production lines at Lonzas site in Portsmouth, Ne…
-
Business17 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News17 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business13 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News16 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses